后入路注射臭氧加亚甲蓝治疗腰椎间盘突出症的临床价值  

Clinical value of percutaneous medical ozone with methylene blue injection through posterior route in treatment of lumbar disc herniation

作　　者：徐仁良[1] 华双一[1] 江根玉 赵红波[1] 

机构地区：[1]海军安庆医院介入放射科,安徽安庆246003

出　　处：《颈腰痛杂志》2015年第2期123-124,122,共3页The Journal of Cervicodynia and Lumbodynia

摘　　要：目的探讨后入路注射臭氧加亚甲蓝治疗腰椎间盘突出症的临床疗效。方法回顾分析116例在我院接受后入路注射臭氧加亚甲蓝治疗的腰突症患者,分别从3个月、6个月、1年的随访资料总结。结果 116例患者按Mac Nab分级法,优56例,良35例,可17例,差8例,总有效率3个月93.1%,6个月91.7%,1年88.9%。结论后入路注射臭氧加亚甲蓝治疗腰椎间盘突出症较臭氧或亚甲蓝单一治疗效果明显提高,且微创安全。Objective To observe the clinical effect of percutaneous medical ozone with methylene blue injection through posterior route in treatment of lumbar disc herniation. Methods The clinical data of 116 cases with lumbar disc herniation in our hospital treated by percuta- neous medical ozone with methylene blue injection through posterior route were retrospectively analyzed. The follow-up data of 3 months,6 months and 1 year were summarized. Results 116 patients according to the modified MacNab criteria,the effect was excellent in 56 cases,fair in 35 cases,acceptable in 17 cases,and poor in 8 cases. The total effective rates were 93.1% at 3 months,91.7% at6 months,88.9% at 1 year. Conclusion The curative effect of percutaneous medical ozone with methylene blue injection through posterior mute in treatment of lumbar disc herniation is obviously better than the single treatment of ozone or methylene blue. This tech- nique is minimally invasive with safety.

关 键 词：椎间盘突出症 臭氧 亚甲蓝 

分 类 号：R681.53[医药卫生—骨科学]